Manufacturer profile

VENTANA MEDICAL SYSTEMS INC.

IndonesiaUnited States20 products registered

VerifiedKemenkes (Ministry of Health) · official registry

Total Products

Product Names

Product Classes

Risk Classes

Regulatory footprint

Search VENTANA MEDICAL SYSTEMS INC. across other regulatory registries

Risk classification breakdown

Distribution of products across risk classes

Kelas Resiko : A1785.0% of total

Kelas Resiko : B210.0% of total

Kelas Resiko : C15.0% of total

Product class portfolio

Products organized by product class

Kelas : 1

VENTANA HybReady Solution, VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody, VENTANA Anti-ALK (D5F3) Rabbit Monoclonal Primary Antibody, ULTRA Cell Conditioning Solution (ULTRA CC1), ULTRA Cell Conditioning Solution (ULTRA CC2) ... and 12 more products in this class

17 Products

Kelas : 2

VENTANA HER2 Dual ISH 3-in-1 Xenograft Slides, BENCHMARK GX and Accessories, BENCHMARK XT AND Accessories

3 Products

Recent registrations (20 most recent)

Most recently registered products with Ministry of Health

VENTANA HybReady Solution

Oct 14, 2024

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA HER2 Dual ISH 3-in-1 Xenograft Slides

Oct 14, 2024

Class: Kelas : 2
Risk Class: Kelas Resiko : C

BENCHMARK GX and Accessories

Apr 4, 2024

Class: Kelas : 2
Risk Class: Kelas Resiko : B

VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody

Mar 25, 2024

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA Anti-ALK (D5F3) Rabbit Monoclonal Primary Antibody

Nov 29, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

ULTRA Cell Conditioning Solution (ULTRA CC1)

Nov 4, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

ULTRA Cell Conditioning Solution (ULTRA CC2)

Nov 2, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

BENCHMARK XT AND Accessories

Jun 1, 2023

Class: Kelas : 2
Risk Class: Kelas Resiko : B

VENTANA Confirm anti-Topoisomerase II Alpha (JS5B4) Rabbit Monoclonal Primary Antibody

May 25, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA Confirm Anti-Ki-67 (30-9) Rabbit Monoclonal Primary Antibody

May 23, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA Confirm anti-Progesterone Receptor (PR) (1E2) Rabbit Monoclonal Primary Antibody

May 23, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA Cell Conditioning Solution (CC1)

May 22, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA Antibody Diluent

May 20, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA LCS (Predilute)

May 20, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA CONFIRM anti-Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Antibody

May 20, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA CONFIRM anti-Vimentin (V9) Primary Antibody

May 17, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA Cell Conditioning Solution (CC2)

May 16, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA ISH Protease 2

May 12, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

WINDOW Hematoxylin II

May 12, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

VENTANA ISH Protease 1

May 12, 2023

Class: Kelas : 1
Risk Class: Kelas Resiko : A

About this profile

VENTANA MEDICAL SYSTEMS INC. from United States is a medical device manufacturer with 20 registered products in the Indonesia Ministry of Health database through Pure Global AI's free platform. The company produces 20 unique product types across 2 product classes.

This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.